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Abstract 
Objectives: To evaluate the feasibility (population reached, costs) and effectiveness (positivity rates, 
linkage to care) of two strategies of community-based HIV testing and counselling (HTC) in rural 
Swaziland.  
Methods: Strategies used were mobile-HTC (MHTC) and home-based-HTC (HBHTC). Information on 
age, sex, previous testing and HIV results was obtained from routine HTC records. A consecutive se-
ries of individuals testing HIV-positive were followed-up for 6 months from the test date in order to 
assess linkage to care. 
Results: 9,060 people were tested: 2,034 through MHTC and 7,026 through HBHTC. A higher propor-
tion of children and adolescents (<20 years) were tested through HBHTC than MHTC (57% vs. 17%; 
p<0.001). MHTC reached a higher proportion of adult men than HBHTC (42% vs. 39%; p=0.015). Of 
398 HIV-positive individuals, only 135 (34%) were enrolled in HIV care within 6 months. Of 42 indi-
viduals eligible for Antiretroviral Therapy, 22 (52%) started treatment within 6 months. Linkage to 
care was lowest among people who had tested previously and those aged 20-40 years. HBHTC was 
50% cheaper (US$11 per person tested, $797 per individual enrolled in HIV care) than MHTC ($24 
and $1698, respectively).  
Conclusion: In this high HIV prevalence setting, a community-based testing programme achieved 
high uptake of testing, and appears to be an effective and affordable way to encourage large num-
bers of people to learn their HIV status (particularly underserved populations such as men and young 
people). However, for community HTC to impact mortality and incidence, strategies need to be im-
plemented to ensure people testing HIV-positive in the community are linked to HIV care. 
 
Keywords: AIDS, HIV testing and counselling, HIV prevention, community-based interventions, HIV 
diagnosis and management. 
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Introduction 
Despite intense global commitment to fight HIV/AIDS and years of preventative campaigns, there 
were an estimated 1.6 million AIDS related deaths in 2012 (73% of which were in sub-Saharan Af-
rica), and 2.3 million new infections1. There is a growing body of evidence showing that a reduction 
in HIV transmission at population level can be achieved through high coverage of regular HIV testing 
combined with access to lifelong antiretroviral therapy (ART) of all identified HIV positive 
individuals2–5. Swaziland has the highest HIV prevalence in the world: approximately 31% of 18-49 
year olds are HIV positive, and it is estimated that each year 2.4 % of HIV negative Swazis become 
HIV positive6. Despite substantial efforts to expand access to HIV testing and counselling (HTC), more 
than one in three HIV-infected adults in Swaziland are unaware of their status6. 
In many generalised epidemics, including Swaziland, HTC coverage is higher among women 
than men7. This difference is largely explained by routine HIV testing in ante-natal care services; in 
Swaziland 94% of pregnant women undergo HIV testing8. Furthermore, the rural clinics in Swaziland 
were originally developed as maternal and child health services. Although they now provide primary 
health care including integrated HIV and tuberculosis care, it is possible that men are reluctant to at-
tend as that they still perceive them to be ‘female’ spaces. Offering HTC in the community repre-
sents a crucial strategy for increasing HTC coverage among individuals who do not use health ser-
vices regularly such as young men or individuals with work related barriers9.  
Both home-based HTC (HBHCT) and mobile-HTC (MHTC) have been successfully imple-
mented in several sub-Saharan settings, demonstrating high uptake and high acceptability10–12. Rela-
tive to facility-based HTC, community-based strategies have been shown to reach HIV-positive popu-
lations earlier in the course of their HIV infection12, thereby enabling earlier access to treatment and 
a reduction in avoidable morbidity, mortality, and transmission of the virus. In 2012, Médecins Sans 
Frontières (MSF) introduced intensive community-based HTC in the rural Shiselweni region of the 
country in collaboration with the Regional Health Department of the Ministry of Health (MoH) of 
Swaziland.  
While it is clear that community-based HTC increases the number of people who learn their 
status, it must also be recognised that it may increase the proportion of HIV infected persons who 
know their positive status but fail to enrol in HIV programmes. A study from Malawi showed that of 
837 screened HIV-positive, only 209 (27%) completed CD4 staging13. In fact significant drop-offs at all 
steps in the cascade from HIV testing to treatment have been described, between enrolment and 
ART initiation, adherence after initiation14–16. Gardner et al showed that even with an ART coverage 
rate of 75% this translated to only 19% of all persons with HIV being on treatment and adherent as 
shown by a supressed viral load17. It has been suggested that men, young adults and people with 
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work related barriers are at risk for not accessing care18. When evaluating HTC strategies, exploring 
the factors associated with failed linkage to care is essential, as this can enable development of more 
focussed interventions during and after post-test counselling which target those most at risk of not 
linking to care15.  
Here, we describe the characteristics of the population reached, and the costs of HBHTC and 
MHTC in rural Swaziland. We also determine if the people who tested HIV positive subsequently ac-
cessed HIV care services, underwent antiretroviral treatment eligibility determination, and, for those 
who were eligible, started treatment. The overall objective of this study was to describe the experi-
ence of community-based HTC approaches in the generalised epidemic context of Swaziland, to in-
form national and regional HIV programming. 
 
Methods 
Setting 
Swaziland is a landlocked lower-middle income country in Southern Africa, with a population of 1.2 
million. This study was carried out in the Shiselweni region, approximately one quarter of the geo-
graphical area of the country, and has a relatively poor rural population. The region had an esti-
mated 41,000 people who are HIV positive, of whom approximately 15,000 were thought to be un-
aware of their status6,7. There were a total of 25 health facilities in Shiselweni during the time of the 
study, three secondary health facilities and 22 rural clinics. All facilities had integrated HIV and tu-
berculosis care and were owned and managed by the Swaziland Ministry of Health, supported by 
MSF. For HTC, the country uses a serial testing algorithm, starting with the Determine HIV1/2. If 
positive the more specific Unigold HIV1/2 test is used for confirmation. If after these two tests, the 
HIV status remains indeterminate (e.g. one positive one negative), a dry blood spot (DBS) sample is 
sent to the National Reference Laboratory for Enzyme-Linked Immunosorbent Assay (ELISA) test-
ing19. 
Specific details of the testing strategy used are available in online supplementary informa-
tion S1. Briefly, two different community-based HTC strategies were evaluated. The first strategy 
was Mobile HTC (MHTC), introduced on an on-going basis from September 2012. MSF testing teams 
visited community sites identified by community leaders, attended mobile ‘outreach’ clinics and set 
up testing sites at major events. The second strategy was Home-based HTC (HBHTC), implemented 
on a campaign basis in August 2013. The campaign took place in three remote communities that 
were sensitized ahead of time via radio announcements. During the campaign the testers moved 
through the community by foot visiting the households door to door.  
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In accordance with national HTC guidelines, individuals who gave informed consent were 
considered eligible for HTC provided they were over 12 years of age and deemed by the health 
worker to be competent to make this decision; those under 12, or lacking competence to consent, 
were tested if a legal guardian provided consent on their behalf19. No specific algorithm assessing 
was used to determine HIV risk among children and adolescents, such that all individuals aged over 
18 months were considered eligible for testing. Children under the age of 18 months were referred 
to the nearest health facility in accordance with national guidelines, since a positive test would re-
quire virological confirmation which is currently only provided at health facilities. Individuals who 
tested HIV positive or had indeterminate test results were referred to the health facility of their 
choice at a date of their choice (recommended to be no later than 14 days). For the purpose of the 
study we visited the structures to ascertain whether the individuals had attended their referral ap-
pointment and were subsequently enrolled in the National HIV programme. Tracing individuals who 
missed their appointment followed national protocol, and was led by the nurses and expert client 
counsellors in the health centres (see supplementary information S1; referral process). Antiretroviral 
treatment eligibility assessment through Point-of-Care (PoC) CD4 testing or WHO staging was not 
provided at the community testing events.  
 
Population and data collection 
To determine the characteristics of the population undergoing HTC in the community, individual 
level data were obtained from paper testing records of two consecutive samples (Subgroups 1 & 2: 
Individuals tested from 01/08/2013-30/08/2013 for HBHTC; and individuals tested from 15/03/2013 
– 17/0572013 for MHTC). For MHTC, detailed information was also collected regarding the type of 
event, and categorised as: 
 (1) Testing at comprehensive outreach: mobile “outreach” clinics organised in collaboration with 
Ministry of Health (MOH) facilities. MOH staff were present offering primary health care services 
while MSF provided logistical support and offered HTC.  
 (2) MSF-led mobile testing. MSF testing teams set up tents and offered HTC at community sites 
identified by community leaders or workplaces.  
 (3) Testing at major events such as football matches or world AIDS day. If more than one site was 
visited in one day, the information regarding each site was collected accordingly, and they were con-
sidered as 2 separate testing events. 
To determine the proportion of HIV positive patients who were successfully linked to HIV 
care (registered in the HIV programme at their chosen facility within 6 months), a consecutive sam-
ple of community-based testing participants who tested HIV positive (or had an indeterminate HIV 
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result) was followed up for six months from the test date (Subgroup 3: Individuals testing HIV posi-
tive from 11/02/2013 – 29/08/2013). MSF data clerks visited each of the health facilities in the re-
gion to trace referrals using the Swaziland HTC client record. This triplicate form has a unique form 
number allowing the data clerks to identify individuals who had attended their appointment. Given 
that some individuals may have sought care without using the referral form, the data clerks also per-
formed a manual search of clinic HIV care records (paper ART and pre-ART registers) using name, 
age, village and date. Clients who were referred to a health facility outside Shiselweni region were 
excluded from the analysis of linkage to care. We did not follow referrals to preventative services for 
clients that tested HIV negative.  
 
Costing 
The cost of MHTC and HBHTC was estimated from a service provider perspective using an ingredient 
costing approach20, whereby the total costs of each testing strategy was estimated and divided by 
the total number of tests done, individuals newly identified as HIV positive, and HIV-positive indi-
viduals linked to HIV care within six months. Further details of the costing analysis can be found in 
Supplementary Information S2.  
 
Data analysis 
To estimate testing coverage through HBHTC we obtained estimates regarding the number of home-
steads and total population from the local councils. For MHTC we did not estimate coverage or up-
take due to the lack of a realistic target population (denominator) and the difficulty in determining 
who was really offered the test and who refused the test due to having a known HIV positive status. 
With regard to the demographic characteristics of the population reached, statistical comparisons 
between the two strategies were made with regard to the main indicators (gender, previous testing 
and HIV positivity) among adults only (≥20 years) using a Pearson’s Chi squared test. Linkage to care 
was defined as attendance at the referral facility and registration in the pre-ART register within six 
months of the test date. Linkage status was established for all individuals who tested HIV positive, ir-
respective of their expressed motivation to seek treatment and care, unless they intended to access 
care outside Shiselweni (and thus could not be followed-up). To analyse factors associated with link-
age to care, Odds Ratios (OR) and 95% confidence intervals (95%CI) were calculated using uncondi-
tional logistic regression. Variables that were associated with linkage in univariable analysis with a p-
value of <0.10 were included in the multivariable model. Data entry was carried out using Epidata 
3.1. and data analysis used Stata/SE Version 12 (StataCorp, Texas, U.S.A.) 
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Ethics  
This study used routine programme data without patient identifiers. The study was approved by the 
Swaziland Scientific and Ethics Committee; and met the criteria for exemption from full ethics review 
from the international MSF ERB. Both institutional review boards waived the need for written in-
formed consent. 
 
Results 
Testing coverage and uptake 
We analysed a consecutive sample of 2,043 people tested through MHTC (Figure 1, subgroup 1.) 
There were a total of 135 events, of which 37 (27%) were comprehensive outreach events (run by 
clinics), 83 (62%) were MSF run mobile testing events and 15 (11%) were organised around a major 
event. In the month of August, 7,026 individuals were tested through an intensive HBHTC campaign 
in the three rural constituencies (Figure 1, subgroup 2). 2,005 (26%) of 7,681 homesteads were 
tested. The main reason for homesteads not being reached was lack of time; each constituency was 
tested over seven consecutive days and this was not sufficient to reach all homesteads in this rural 
setting.  
 According to local council records, a total of 12,269 people lived in the 2,005 households 
that were visited during the HBHTC campaign. 8,768 (71%) were present the day of testing. 673 (8%) 
of those present had a known HIV positive status and 395 (5%) reported that they knew their status 
as they had tested negative in the previous 2 months. Of the remaining 7,484 individuals, 6,452 
(86%) were tested. A further 597 individuals were tested outside the households. 
 
Demographics and previous testing among the population reached by MHTC and HBHTC 
A higher proportion of children and adolescents were tested during the HBHTC campaign than by 
MHTC (p<0.001). 110 (5.4%) of those tested through MHTC were under the age of 10; 245 (12%) 
were adolescents (10-19 years old) and 1,679 (83%) were adults (20 years or older). By contrast, 
2086 (30%) of those tested by HBHTC were children under the age of 10, and 1924 (27%) were ado-
lescents, and 3016 (43%) were adults. Given the equal gender-distribution among children and the 
fact that children & adolescents were more likely to be first-time testers, comparisons between 
HBHTC and MHTC in terms of gender and previous testing were made among the adult population 
only. Details of the gender and previous testing characteristics among the children and adolescents 
can be found in Table 1.  
Among adults, a higher proportion of men were tested by MHTC than HBHTC (702, 42% vs. 
1163, 39%, p=0.020). The proportion of males tested was higher among the subgroup of MHTC that 
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were categorised as major events, where 243 of 426 people tested were male (57%, data not shown 
in tables).  
Of the adults tested through HBHTC, 1,013 (34%) were testing for the first time. This was 
significantly higher than for MHTC (359, 22%, p<0.001). Similarly, the proportion of adults who had 
not tested within the last 12 months was higher among those tested by HBHTC compared to MHTC 
(Table 1, p>0.001).  
 
HIV positivity rate 
Overall, the HIV positivity rate was highest among those tested though MHTC where 96 individuals 
(4.7%) tested HIV positive vs. 243 (3.5%) of those tested by HBHTC (p=0.009). The number needed to 
screen to identify one HIV positive individual was 21 (95%CI: 17- 26) for MHTC and 29 (95%CI: 26 - 
33) for HBHTC. Among adults only, there was no difference in the HIV positivity rates between the 
two strategies (Table 1, p=0.285), with 5-6% found to be HIV positive through either strategy. The 
number of adults needed to screen to identify one HIV positive individual was 18 (95%CI: 15- 23) for 
MHTC and 16 (95%CI: 14- 18) for HBHTC. Of the 4,010 children and adolescents tested during the 
HBHTC campaign, 53 (1.3%) tested HIV positive and a further three had indeterminate test results.  
 
Linkage to HIV care 
We analysed a consecutive sample of 439 individuals that tested HIV positive at a MHTC event or 
during the HBHTC campaign (Figure 1, subgroup 3). Of the 398 HIV positive individuals referred 
within Shiselweni, 135 (34%) were registered in pre-ART care within six months of the test date (fig-
ure 2). Of these, 103 (76%) had a CD4 count taken and completed ART eligibility assessment (equiva-
lent to 26% of those tested HIV positive). Forty-two (41%) were eligible for combined ART according 
to national guidelines (CD4<350 and/or WHO clinical stages III or IV), of whom 22 (52%) initiated 
treatment. The median time from HIV testing to pre-ART enrolment was 12 days (IQR 6 – 29 days), 
and the median time from HIV test to ART initiation was 34 days (IQR 20 – 60).  
There was no difference in linkage to care between the two testing strategies or between 
men and women (Table 2). Linkage to care was highest among children and older individuals (ap-
proximately half of the children aged 18 months to nine years or adults aged over 50 were linked to 
care, Table 2). Particularly low rates of linkage to care were observed for individuals aged 20-29 and 
30-39 years old (Table 2). Enrolment in HIV care was highest among first time testers (44% compared 
to 28% of those who had tested previously, p=0.004). Single people were less likely seek HIV care 
than individuals who reported being married or living in stable partnership although this association 
lost statistical significance after controlling for age and previous testing (Table 2). Of four individuals 
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who had indeterminate test results and were referred to a facility within Shiselweni, none were 
linked to care within 6 months and hence none were re-tested.  
 
Cost of MHTC and HBHTC campaign 
From service provider perspective, HBHTC was significantly cheaper ($11 per person tested, $343 
per HIV positive individual identified, and $797 per HIV positive individual linked-to-care) than MHTC 
($24, $543 and $1 698 respectively, Table 3). The main cost driver for HBHTC was accomodation and 
food for staff during the campaign, accounting for nearly one third of the total costs (Table 3). The 
main cost drivers for MHTC was human resources, followed by transport costs.  
 
Discussion 
We found mobile and home-based HTC to be feasible and affordable ways to reach a substantial 
number of people, and hence have the potential to increase the number of people who know their 
HIV status, in this rural, low-resourced, high prevalence setting of Swaziland. Rates of sero-positivity 
were similar between strategies, but HBHTC cost 50% less than the mobile strategies, and was a 
more effective strategy for reaching first time testers. MHTC appeared more effective for reaching 
specific target groups (such as men), and thus both testing strategies may have a complementary 
role to play, depending on the specific objectives of the testing program. Only one third of those 
testing HIV positive were subsequently enrolled in pre-ART care, and hence ensuring that people 
who test HIV positive in the community access HIV prevention and care services remains a significant 
challenge in this setting.  
In high-prevalence generalised HIV epidemics, as is the case in Swaziland, increasing the 
proportion of people who know their HIV status is an important public health goal, and both strate-
gies evaluated contributed to this process (almost half of those testing in the Shiselweni region in 
this evaluation period were tested by this small community team). A significant number of children 
were tested by HBHTC; 54 tested HIV positive, of whom 22 were under the age of 10, which demon-
strates the potential of HBHTC for reaching HIV-positive children missed by the PMTCT programme 
and child welfare services. Community testing offering HIV testing to all individuals over 18 months 
of age, can therefore complement the detection of HIV positive children for linkage into HIV care 
and treatment. Other studies have also identified home-based testing to be a good strategy to target 
children21,22. Furthermore, we showed that HBHTC was a more effective strategy for reaching people 
who are over-due for retesting (national HTC guidelines recommend that HIV negative adults un-
dergo yearly testing)19. In a high incidence setting, increasing rates of annual re-testing is of particu-
lar relevance, as identifying people with HIV infection, who believe they are still HIV negative, may 
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be an important element of transmission reduction.  
The costs reported here for both HBHTC and MHTC here were comparable to those summa-
rised in a recent systematic review12. It is worth noting that HBHTC in this study was carried out in 
the form of an intensive door-to-door campaign with supplementary working hours for the testing 
teams, and as such incurred some additional costs (staff accommodation and food) that could be 
avoided to make the activity more economical. However, it is difficult to calculate what impact this 
would have on costs since the number of people tested during the campaign is likely to be higher 
than the number tested if door-to-door testing were to be undertaken as a routine activity. Relative 
to HBHTC, MHTC was significantly more expensive which can be explained by the fact that some 
mobile events had very low attendance levels (e.g. remote communities), yet HR and transport costs 
remained constant. If MHTC is directed at high risk groups with poor access to HTC, it is possible that 
even when testing numbers are low the number of HIV-positive individuals identified will increase 
and the cost per HIV-positive individual identified will be reduced.   
A key challenge highlighted in our study was the low rate of linkage to HIV care among indi-
viduals who tested HIV-positive. If linkage to HIV care for HIV positive individuals were the sole ob-
jective of HTC, the community based strategies as described here could not be deemed effective. 
Two-thirds of the HIV-positive individuals identified were not registered in HIV care within 6 months 
of the test. While high-levels of attrition after HIV testing have been observed in numerous studies14–
16,23,24, some studies have shown relatively high levels of linkage10,12 . In light of our findings, and re-
viewing the details of the different studies, it appears that PoC ART eligibility determination could be 
a valuable addition to HBHTC and MHTC programmes, for the purposes of increasing linkage of HIV 
positive people to HIV care. Nevertheless, determination of ART eligibility does not guarantee that 
an individual initiates ART. One study showed that one in five people did not undergo CD4 staging 
even with PoC CD4 available18, and of those that did a further 27% did not receive their results. Fur-
thermore, even when CD4 staging is close to 100%, treatment initiation can be as low as 50%25. In 
our study we found that one in four people attending the clinic did not have CD4 staging recorded, 
and only half of the individuals eligible for ART after CD4 testing and WHO staging, initiated ART 
within six months of the HIV test.  
Linkage to care was especially poor among individuals who had tested in the past. It is possi-
ble that these individuals are more reluctant to believe and act upon the test results, given they had 
had a negative test in the past. Furthermore, we showed linkage was low among people aged 20 to 
40, which may reflect occupational barriers preventing these individuals from attending the clinic for 
HIV care. However, it is alarming that linkage to care was not higher than 50% for any of the sub-
groups considered. Strategies to improve linkage to care and to reduce attrition between testing and 
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treatment initiation are urgently needed23. Providing incentives has been suggested to have positive 
impact on linkage rates26, as has incorporating POC CD4 counts and follow-up visits by a lay-
counsellor27. Reducing the number of health facility visits has also been suggested as a key facilitator 
for improving access26. Indeed one study in Malawi has shown that offering home initiation after 
home self testing significantly increased the proportion of adults initiating ART28.  
 During the HBHTC campaign, nearly a third of the reported households members were not 
present the day of testing, perhaps due to work commitments. Improving HBHTC testing coverage by 
visiting the homesteads in the evenings may be a useful strategy to reduce health inequalities 
caused by work related barriers. HBHTC was introduced as a campaign and it is not clear if uptake 
(acceptance) would be similarly high if HBHTC were to be carried out on a routine basis or if recur-
rent campaigns were to take place. Furthermore, it is important to respect the opt-in nature of 
HBHTC as concerns have been raised about HBHTC and the possibility of household members par-
ticipating in HTC under coercion. In our analysis of factors associated with linkage to care, one key 
limitation was the lack of availability of CD4 or WHO staging to determine eligibility for ART. It is pos-
sible that individuals who feel healthy are less likely to attend the clinic, potentially acting as a con-
founder in our risk-factor analysis. Finally, we must recognise as a limitation that our costing analysis 
is limited to the service-provider’s perspective. However, if we had considered the patient perspec-
tive, both community-based HTC strategies are likely to be even more cost-effective because from a 
patient perspective the main costs are transport costs (to go to a site offering HTC) and opportunity 
cost (loss of time travelling to the HTC site and waiting for ones turn to test). 
 In conclusion, community-based testing appears to be an effective and affordable way to 
improve HTC coverage in high-prevalence settings. We found that HBHTC cost less than MHTC and 
was more effective at reaching first time testers and people who had not tested in the past 12 
months. Furthermore, in a setting with high antenatal HIV prevalence and low coverage of infant 
testing throughout breastfeeding, HBHTC enabled identification of HIV positive children missed by 
the PMTCT programme and child welfare services. MHTC, although more expensive, can still be a 
useful strategy to reach specific target groups with poor access to HTC (e.g. young men or people 
with work-related barriers). Community-based testing can thus contribute to increasing the number 
of people who know their HIV status. However, for it to have impact on HIV morbidity, mortality and 
incidence, it should include not only PoC treatment eligibility determination but also other “direc-
tive” linkage strategies to help guide people testing HIV positive in the community into HIV care and 
treatment. 
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Tables 
Table 1: Population reached by Community Testing Strategies in Swaziland   
 
 MHTC HBHTC  
  Children 
 (1-9yrs) 
Adolescen
t  
(10-
19yrs) 
Adult 
(≥20yrs) Total
1 Children
 (1-9yrs)
Adolescen
t  
(10-
19yrs) 
Adult  
(≥20yrs) Total
1 P 2 
  n % n % N % n % n % n % N % n %  
Total 
11
0 - 245 - 
167
9 - 
203
4 - 
208
6 - 1924 - 
301
6 - 
702
6 -  
Gender:                          
Male 50 46% 142 58% 703 42% 895
44
%
102
5 
49
% 918 48%
116
3 
39
% 
310
6 
44
% 0.020
Female 58 54% 103 42% 969 58%
113
0 
56
%
105
8 
51
% 1005 52%
185
1 
61
% 
391
4 
56
%  
Previous HIV 
test:                          
Never  91 83% 153 63% 359 22% 603
30
%
189
9 
92
% 1576 83%
101
3 
34
% 
448
8 
64
% 
<0.00
1 
Within last 
12 months 9 8% 56 23% 715
43
% 780
39
% 57 3% 113 6% 781 
26
% 951 
14
%  
Over a year 
ago 9 8% 35 14% 592
35
% 636
32
% 114 6% 219 11%
118
1 
40
% 
151
4 
22
%  
HIV test result:                          
Negative 109 
100
% 240 98%
157
8 
95
%
192
7 
94
%
205
8 
99
% 1884 98%
280
6 
94
% 
674
8 
96
% 0.285
Positive  0 - 5 2% 91 5% 96 6% 21 1% 32 2% 189 6% 242 4%  
Indeterminat
e 0 - 0 - 0 0% 0 0% 0 - 3 0% 2 0% 5 0%  
132 individuals has missing information on age and do not appear in this table. Furthermore, the sum of the 
subtotals does not add up to the total because 1 (0.01%) individual had missing information on gender, 75 
(0.83%) had missing info for previous HIV testing and 42 (0.5%) had a missing HIV test result. 
2 P value from Pearson’s Chi squared test comparing proportions among adults only 
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Table 2: Factors associated with linkage to care among individuals testing HIV+ or with inde-
terminate test results in community-based testing events.  
 N Linked to HIV care facil-
ity within 6 months 
P Crude Odds Ra-
tio (95% CI) 
Adjusted Odds 
Ratio (95% CI) 
Total 398 135 (34%)    
Strategy type      
MHTC  228 60 (35%) 0.617 1 - 
HBHTC 170 75 (33%)  1.1 (0.7 – 1.7) - 
Age      
Children (1-9 yrs) 14 7 (50%) 0.001 3.4 (1.1 – 10.6) 3.1 (0.9 – 10.1) 
Adolescents (10-
19yrs) 
33 14 (42%)  2.5 (1.1 – 5.7) 2.5 (1.0 – 6.0) 
Adults (20-29yrs) 120 27 (23%)  1 1 
Adults (30-39yrs) 104 28 (27%)  1.3 (0.7 – 2.3) 1.1 (0.6 – 2.1) 
Adults (40-49yrs) 62 27 (44%)  2.7 (1.4 – 5.1) 2.2 (1.1 – 4.5) 
Adults (≥ 50 yrs) 60 30 (50%)  3.4 (1.7 – 6.7) 2.3 (1.1 – 5.0) 
Gender      
Female 242 84 (35%)  1 - 
Male 155 51 (33%) 0.711 0.9 (0.6 – 1.4) - 
Previous HIV test:      
Never  161 71 (44%) 0.004 1 1 
Within last 12 
months 
70 19 (27%)  0.4 (0.3 – 0.9) 0.5 (0.3 – 1.0) 
Over a year ago 160 45 (28%)  0.5 (0.3 – 0.8) 0.6 (0.3 – 0.9) 
Marital status      
Single/separated 153 44 (29%) 0.044 1 1 
Married/cohabitation 194 67 (36%) 1.3 (0.8 – 2.1) 1.5 (0.9 – 2.7)
Widowed 38 19 (50%)  2.5 (1.2 – 5.1) 2.1 (0.9 – 5.2) 
NB: 5 (1.3%) had missing information on age, 1 (0.3%) on sex, 7 (1.8%) on previous testing and 19 (4.7%) on 
marital status. 
 
Table 3: Cost of community-based HIV testing strategies led by MSF in Shiselweni, Swaziland, 
2013.  
 MHTC HBHTC 
Cost per person reached 24 USD 11 USD 
Cost per HIV positive identified 543 USD 343 USD 
Cost per HIV positive identified and linked to care 1698 USD 797 USD 
   
Break-up of costs:   
Transport 25% 6% 
Human Resources 52% 26% 
Testing equipment 16% 30% 
Infection Control 2% 1% 
Information, Education & Counselling 1% 3% 
Other1 3% 33% 
1Other costs included trailers, tents, furniture for MHTC; accommodation, food, airtime for HBHTC. 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
 
A
cc
ep
te
d 
A
rt
ic
le
This article is protected by copyright. All rights reserved. 
Figure 2: Linkage-to-care, assessment of ART eligibility and treatment initiation among indi-
viduals testing HIV+ through community testing in Shiselweni, Swaziland 
 
 
(1) Treatment eligibility was defined as any client with CD4<350 and/or WHO III/IV stage 
 
 
398 HIV+ tested in by MHTC or HBHTC from 
11th Feb – 29th Aug 2013 (subgroup 3)
135 (34%) linked to HIV care 
facility within 6 months
103 (76%) treatment 
eligibility(1) assessed
42 (41%) CD4<350 and/or 
WHO stage III/IV
22(52%) intiated 
combined ART 
20 (48%) had not initiated 
ART 6 months after HIV 
test
61 (59%) CD4>350 and 
WHO stage I or II
32 (24%) no information regarding 
CD4 or WHO staging
263(66%) not linked to HIV care 
facility 6 months after HIV+ test
